Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 4, 2009, Pages 494-499

  Joseph, B V ^a   Soman, S ^a   Radhakrishnan, I ^a,b   Madhavilatha, G K ^a   Paul, L K ^a   Mundayoor, S ^a   Kumar, R A ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

Alamar blue; India; Kerala; MOTT; Multidrug resistant tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM ANALYSIS; TREATMENT FAILURE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INDIA; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 64749108355     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. World Health Organization. 2007 tuberculosis facts. Geneva, Switzerland: WHO, 2007. http://www.who.int/tb/publications/2007/factsheet-2007.pdf Accessed April 2008.
2. Revised National Tuberculosis Control Programme. TB India 2008-RNTCP status report. New Delhi, India: Central TB Division Directorate General of Health Services, 2008. http://www.tbcindia.org Accessed April 2008.
3. Cohn D, Bustreo F, Raviglione M. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clin Infect Dis 1997; 24 (Suppl 1): S121-S130.
4. Petroff S. A new and rapid method for the isolation of tubercle bacilli directly from the sputum and feces. J Exp Med 1915; 21: 38-42.
5. Kumar R A, Paul L, Radhakrishnan I, et al. Analysis of drug susceptibility in Mycobacterium tuberculosis isolated from Thiruvananthapuram using Alamar Blue assay. Curr Sci 2001; 80: 70-73.
6. Collins L, Franzblau S G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997; 41: 1004- 1009.
7. Bastian I, Rigouts L, Palomino J C, Portaels F. Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method. Antimicrob Agents Chemother 2001; 45: 1934-1936.
8. Martin A, Camacho M, Portaels F, Palomino J C. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple and inexpensive method. Antimicrob Agents Chemother 2003; 47: 3616-3619.
9. Gamboa F, Cardona P J, Manterola J M, et al. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998; 17: 189-192.
10. Traore H, Fissette K, Bastian I, Devleeschouwer M, Portaels F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000; 4: 481-484.
11. Watterson S A, Wilson S M, Yates M D, Drobniewski F A. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1969-1973.
12. Yajko D M, Madej J J, Lancaster M V, et al. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol 1995; 33: 2324- 2327.
13. Franzblau S G, Witzig R S, McLaughlin J C, et al. Rapid, low- technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 1998; 36: 362-366.
14. Pfyffer G E, Strassle A, Van Gorkum T, et al. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 2001; 7: 855-861.
15. Martin A, Portaels F C, Palomino J C. Colorimetric redox- indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 59: 175-183.
16. Chauca J A, Palomino J C, Guerra H. Evaluation of the accuracy of the microplate Alamar Blue assay for rapid detection of MDR-TB in Peru. Int JTuberc Lung Dis 2007; 11: 820-822.
17. Jesudason M V, Gladstone P. Non-tuberculous mycobacteria isolated from clinical specimens at a tertiary care hospital in South India. Indian J Med Microbiol 2005; 23: 172-175.
18. Agarwal J, Anupurba S. Isolation rates of mycobacterial species from Varanasi (North India). Indian J Med Microbiol 1999; 17: 178-179.
19. Aggarwal M, Jindal N, Arora R, Aggarwal N P, Arora S. Nontuberculous mycobacteria: the changing scenario at Amritsar. Indian J Tuberc 1993; 40: 25-27.
20. Agarwal A, Jindal N. Isolation rates of non-tuberculous mycobacteria from Amritsar. Indian J Med Microbiol 2001; 19: 230-231.
21. Prasad R. MDR-TB: current Status. Indian J Tuberc 2005; 52: 121-131.
22. Joseph M R, Shoby C T, Amma G R, Chauhan L S, Paramasi- van C N. Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. Int J Tuberc Lung Dis 2007; 4: 443-449.
23. Janmeja A K, Raj B. Acquired drug resistance in tuberculosis in Haryana, India. J Assoc Physicians India 1998; 46: 194-198.
24. Malhotra B, Pathak S, Vyas L, et al. Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Jaipur. Indian J Med Microbiol 2002; 20: 76-78.
25. Jain N K, Chopra K K, Prasad G. Initial and acquired INH and rifampicin resistant to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992; 39: 180-186.
26. Almeida D, Rodrigues C, Udwadia Z F, et al. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis 2003; 36: 52-54.
27. Almeida D, Rodrigues C, Ashavaid T F, Laivani A, Udwadia Z F, Mehta A. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care centre in Mumbai, India. Clin Infect Dis 2005; 40: 881-886.
28. World Health Organization. What is DOTS? A guide to understand the WHO-recommended TB control strategy known as DOTS. Geneva, Switzerland: WHO, 1999. http://www.emro.who.int/stb/media/pdf/whatisDOTS.pdf Accessed June 2008.
29. Crofton J, Chaulet P, Maher D, et al. Guidelines for the management of drug-resistant tuberculosis. WHO/TB/96.210 Revl. Geneva, Switzerland: World Health Organization, 1997. 30 Thankappan K R, Valiathan M S. Health at low cost-the Kerala model. Lancet 1998; 351: 1274-1275.